Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

May 15, 1997

Pharmacokinetics and tissue distribution of TOP-53

May 15, 1997

Samjin characterizes novel antitumor agent

May 14, 1997

In vitro effects of combinations of tubulin-interacting agents and S-16020-2

May 14, 1997

In vivo growth arrest of mammary carcinoma by ibuprofen

May 14, 1997

Dual H1/NK1 antagonist for allergic rhinitis from HMR

May 14, 1997

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

May 14, 1997

In vivo and clinical antitumor activity of recombinant methioninase

May 14, 1997

Lilly synthesizes antifolates that potently inhibit human DHFR

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...